Press Releases on October 13, 2023 - EIN Presswire - Press Release Distribution Service

Published on October 13, 2023 - 13:35 GMT

IBN and InvestorWire Join Forces to Amplify Octane’s 2023 Medical Innovation Forum

IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (“InvestorBrandNetwork”), a pioneering corporate communications firm and content distributor, is excited to announce its collaboration with Octane as Official Media Partner for its …

Distribution channels: Companies, Media, Advertising & PR ...

Published on October 13, 2023 - 13:33 GMT

Financial Advisor Natalea Simmons Joins Stifel In Suburban St. Louis

ST. LOUIS, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that financial advisor Natalea Simmons has joined the firm’s Stifel, Nicolaus & Company, Incorporated broker-dealer subsidiary in Frontenac, Missouri. Ms. …

Distribution channels:

Published on October 13, 2023 - 13:33 GMT

Investor Alert: Abbott Cooper PLLC Announces Investigation into Evelo Biosciences, Inc.; Urges Evelo Stockholders to Contact ...

STAMFORD, Conn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Evelo Biosciences, Inc. (NASDAQ: EVLO) (“Evelo” or the “Company”) on behalf of the Company’s investors to determine whether Evelo’s board of directors has violated …

Distribution channels: Consumer Goods, Law ...

Published on October 13, 2023 - 13:32 GMT

Summary of opinion: Agamree,Vamorolone, 12/10/2023, Positive

On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Agamree1, intended for the treatment of Duchenne muscular dystrophy ( …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2023 - 13:32 GMT

Summary of opinion: Rubraca,rucaparib, 12/10/2023, Positive

On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Rubraca. The marketing authorisation holder for this …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2023 - 13:32 GMT

Summary of opinion: Keytruda,pembrolizumab, 12/10/2023, Positive

On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Keytruda. The marketing authorisation holder for this …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2023 - 13:32 GMT

Summary of opinion: Veoza,fezolinetant, 12/10/2023, Positive

On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Veoza, intended for the treatment of hot flushes (vasomotor symptoms) …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2023 - 13:32 GMT

Summary of opinion: Praluent,alirocumab, 12/10/2023, Positive

On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Praluent. The marketing authorisation holder for this …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2023 - 13:32 GMT

Summary of opinion: Rezzayo,rezafungin, 12/10/2023, Positive

On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Rezzayo1, intended for the treatment of invasive candidiasis in …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2023 - 13:32 GMT

Summary of opinion: Loargys,Pegzilarginase, 12/10/2023, Positive

On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation under exceptional circumstances1 for the medicinal product Loargys2, intended for the treatment …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2023 - 13:32 GMT

Summary of opinion: Veyvondi,vonicog alfa, 12/10/2023, Positive

On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Veyvondi. The marketing authorisation holder for this …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2023 - 13:31 GMT

Interactive Strength, Inc. d/b/a FORME Announces Strategic Partnership with HSA/FSA Payment Provider Truemed

Collaboration incentivizes U.S. customers to spend funds from HSA (Health Savings Accounts) and FSA (Flexible Spending Accounts) programs to purchase FORME's personal training and smart home gyms with pre-tax dollars Partnership enhances FORME’s B2C …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...